Dianthus Therapeutics 的锁定期将于 2025 年 11 月 9 日到期，结束对内幕股票销售的限制。 Lock-up period for Dianthus Therapeutics expires on Nov. 9, 2025, ending restrictions on insider stock sales.

2025年11月9日,在自9月9日开始的61天限制期之后,Dianthus治疗公司的某些授权令、共同股份、预先供资的授权令和股票选择权的冻结协议将于2025年11月9日到期。 Lock-up agreements for certain warrants, common shares, pre-funded warrants, and stock options of Dianthus Therapeutics, Inc. expire on November 9, 2025, following a 61-day restriction period that began September 9. 该协议是公司最近提供的一部分,它禁止内幕人员和公司未经承保人同意出售或转让这些证券,但允许的例外情况除外。 The agreement, part of the company’s recent offering, prohibits insiders and the company from selling or transferring these securities without underwriter consent, except under permitted exceptions. 这一限制旨在通过限制即时出售来防止市场不稳定。 The restriction aims to prevent market instability by limiting immediate sell-offs.